Lv3
360 积分 2024-11-10 加入
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
24天前
已完结
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
1个月前
已完结
Global epidemiology of heart failure
2个月前
已完结
SNORA33 promotes clear cell renal cell carcinoma development and resistance to sunitinib through triggering the JAK/STAT pathway
2个月前
已完结
DDX18 promotes growth and metastasis of hepatocellular carcinoma via activating EMT and MAPK signaling
2个月前
已完结
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
4个月前
已完结
Regenerating the heart
4个月前
已完结
[SRF promotes the progression of lung adenocarcinoma by regulating lncRNA FGD5-AS1]
4个月前
已完结
[TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR]
4个月前
已完结
[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]
4个月前
已完结
皖公网安备34019202002308
